Cite
Anti-CD71 antibody immunohistochemistry in the diagnosis of acute myeloid leukemia, subtype acute erythroid leukemia with erythroid dominance (AML M6-Er), in a retrovirus-negative cat.
MLA
Suzuki, Satoshi, et al. “Anti-CD71 Antibody Immunohistochemistry in the Diagnosis of Acute Myeloid Leukemia, Subtype Acute Erythroid Leukemia with Erythroid Dominance (AML M6-Er), in a Retrovirus-Negative Cat.” Journal of Veterinary Diagnostic Investigation, vol. 33, no. 1, Jan. 2021, pp. 87–94. EBSCOhost, https://doi.org/10.1177/1040638720973403.
APA
Suzuki, S., Ogino, N., Mitsui, I., Ito, H., & Kariya, T. (2021). Anti-CD71 antibody immunohistochemistry in the diagnosis of acute myeloid leukemia, subtype acute erythroid leukemia with erythroid dominance (AML M6-Er), in a retrovirus-negative cat. Journal of Veterinary Diagnostic Investigation, 33(1), 87–94. https://doi.org/10.1177/1040638720973403
Chicago
Suzuki, Satoshi, Naotaka Ogino, Ikki Mitsui, Hiroyuki Ito, and Takuro Kariya. 2021. “Anti-CD71 Antibody Immunohistochemistry in the Diagnosis of Acute Myeloid Leukemia, Subtype Acute Erythroid Leukemia with Erythroid Dominance (AML M6-Er), in a Retrovirus-Negative Cat.” Journal of Veterinary Diagnostic Investigation 33 (1): 87–94. doi:10.1177/1040638720973403.